Shenzhen Mindray Bio-Medical Electronics Past Earnings Performance
Past criteria checks 3/6
Shenzhen Mindray Bio-Medical Electronics has been growing earnings at an average annual rate of 15.8%, while the Medical Equipment industry saw earnings declining at 3.3% annually. Revenues have been growing at an average rate of 14.6% per year. Shenzhen Mindray Bio-Medical Electronics's return on equity is 25.9%, and it has net margins of 31.3%.
Key information
15.79%
Earnings growth rate
15.88%
EPS growth rate
| Medical Equipment Industry Growth | 15.97% |
| Revenue growth rate | 14.62% |
| Return on equity | 25.88% |
| Net Margin | 31.29% |
| Last Earnings Update | 31 Mar 2025 |
Recent past performance updates
Recent updates
Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Has A Rock Solid Balance Sheet
Mar 24
The Trend Of High Returns At Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Has Us Very Interested
Mar 08Is Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760) Trading At A 44% Discount?
Feb 05There Is A Reason Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) Price Is Undemanding
Jan 20Does Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Have A Healthy Balance Sheet?
Dec 03We Like Shenzhen Mindray Bio-Medical Electronics' (SZSE:300760) Returns And Here's How They're Trending
Nov 18Is There An Opportunity With Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) 27% Undervaluation?
Oct 24Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Ticks All The Boxes When It Comes To Earnings Growth
Oct 08Risks To Shareholder Returns Are Elevated At These Prices For Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760)
Aug 12Shareholders Would Enjoy A Repeat Of Shenzhen Mindray Bio-Medical Electronics' (SZSE:300760) Recent Growth In Returns
Jul 28Estimating The Fair Value Of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760)
Jun 06Revenue & Expenses Breakdown
How Shenzhen Mindray Bio-Medical Electronics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 25 | 35,590 | 11,137 | 6,944 | 3,485 |
| 31 Dec 24 | 36,726 | 11,668 | 7,181 | 3,666 |
| 30 Sep 24 | 37,113 | 12,385 | 6,954 | 3,516 |
| 30 Jun 24 | 36,987 | 12,701 | 6,816 | 3,357 |
| 31 Mar 24 | 35,940 | 12,171 | 6,759 | 3,528 |
| 31 Dec 23 | 34,932 | 11,582 | 6,779 | 3,433 |
| 30 Sep 23 | 34,374 | 11,339 | 6,517 | 3,344 |
| 30 Jun 23 | 33,486 | 10,762 | 7,069 | 3,424 |
| 31 Mar 23 | 31,787 | 10,073 | 6,601 | 3,071 |
| 01 Jan 23 | 30,366 | 9,607 | 6,159 | 2,923 |
| 30 Sep 22 | 29,174 | 9,441 | 5,654 | 2,982 |
| 30 Jun 22 | 27,847 | 8,945 | 5,387 | 2,813 |
| 31 Mar 22 | 26,432 | 8,392 | 5,264 | 2,640 |
| 01 Jan 22 | 25,270 | 8,002 | 5,098 | 2,524 |
| 30 Sep 21 | 24,354 | 7,957 | 4,688 | 2,148 |
| 30 Jun 21 | 23,240 | 7,548 | 4,603 | 2,027 |
| 31 Mar 21 | 22,066 | 7,059 | 4,577 | 1,976 |
| 31 Dec 20 | 21,026 | 6,658 | 4,539 | 1,869 |
| 30 Sep 20 | 20,240 | 6,373 | 4,740 | 1,732 |
| 30 Jun 20 | 18,915 | 5,765 | 4,672 | 1,664 |
| 31 Mar 20 | 17,391 | 4,988 | 4,651 | 1,603 |
| 31 Dec 19 | 16,556 | 4,681 | 4,380 | 1,466 |
| 30 Sep 19 | 15,853 | 4,494 | 4,267 | 1,382 |
| 30 Jun 19 | 15,151 | 4,217 | 4,181 | 1,333 |
| 31 Mar 19 | 14,423 | 3,918 | 4,036 | 1,331 |
| 31 Dec 18 | 13,753 | 3,719 | 3,937 | 1,267 |
| 30 Sep 18 | 13,109 | 3,492 | 3,808 | 1,233 |
| 31 Dec 17 | 11,174 | 2,589 | 3,387 | 1,018 |
| 31 Dec 16 | 9,032 | 1,600 | 4,185 | 0 |
| 31 Dec 15 | 8,013 | 910 | 3,916 | 0 |
| 31 Dec 14 | 7,836 | 1,360 | 3,733 | 0 |
Quality Earnings: 300760 has high quality earnings.
Growing Profit Margin: 300760's current net profit margins (31.3%) are lower than last year (33.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300760's earnings have grown by 15.8% per year over the past 5 years.
Accelerating Growth: 300760's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300760 had negative earnings growth (-8.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (-1.6%).
Return on Equity
High ROE: 300760's Return on Equity (25.9%) is considered high.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/21 08:19 |
| End of Day Share Price | 2025/05/21 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is covered by 46 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhe Sun | BofA Global Research |
| Zhishun Siu | CCB International Securities Limited |
| Jingning Long | Chasing Securities |